| Literature DB >> 26836154 |
Mariacristina Siotto1, Ilaria Simonelli2, Patrizio Pasqualetti3, Stefania Mariani2, Deborah Caprara2, Serena Bucossi4, Mariacarla Ventriglia2,5, Rossana Molinario6, Mirca Antenucci6, Mauro Rongioletti7, Paolo Maria Rossini4,8, Rosanna Squitti2,5.
Abstract
Meta-analyses demonstrate copper involvement in Alzheimer's disease (AD), and the systemic ceruloplasmin status in relation to copper is an emerging issue. To deepen this matter, we evaluated levels of ceruloplasmin concentration, ceruloplasmin activity, ceruloplasmin specific activity (eCp/iCp), copper, non-ceruloplasmin copper iron, transferrin, the ceruloplasmin/transferrin ratio, and the APOE genotype in a sample of 84 AD patients and 58 healthy volunteers. From the univariate logistic analyses we found that ceruloplasmin concentration, eCp/iCp, copper, transferrin, the ceruloplasmin/transferrin ratio, and the APOE genotype were significantly associated with the probability of AD. In the multivariable logistic regression analysis, we selected the best subset of biological predictors by the forward stepwise procedure. The analysis showed a decrease of the risk of having AD for eCp/iCp (p = 0.001) and an increase of this risk for non-ceruloplasmin copper (p = 0.008), age (p = 0.001), and APOE-ɛ4 allele (p < 0.001). The estimated model showed a good power in discriminating AD patients from healthy controls (area under curve: 88% ; sensitivity: 66% ; specificity 93%). These data strength the breakdown of copper homeostasis and propose eCp/iCp as a reliable marker of ceruloplasmin status.Entities:
Keywords: Alzheimer’s disease; ceruloplasmin; ceruloplasmin specific activity; non-ceruloplasmin copper
Mesh:
Substances:
Year: 2016 PMID: 26836154 DOI: 10.3233/JAD-150611
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472